BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 20140781)

  • 21. [Myasthenia gravis and autoimmune dysthyroidism following lymhoma].
    Castro del Río M; Seijo M; Amigo C
    Rev Neurol; 2000 Dec 1-15; 31(11):1099-100. PubMed ID: 11190881
    [No Abstract]   [Full Text] [Related]  

  • 22. Chronic myeloid leukemia presenting as paraneoplastic ocular myasthenia gravis.
    Kumar P; Jain P; Menon H; Purvish P
    Ann Oncol; 2007 Apr; 18(4):804-5. PubMed ID: 17389528
    [No Abstract]   [Full Text] [Related]  

  • 23. Myasthenia gravis with inflammatory myopathy without elevation of creatine kinase.
    Kanbayashi T; Tanaka S; Hatanaka Y; Uchio N; Shimizu J; Sonoo M
    Neuromuscul Disord; 2021 Jun; 31(6):570-573. PubMed ID: 34016494
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dropped head sign as the only symptom of myasthenia gravis.
    Yaguchi H; Takei A; Honma S; Yamashita I; Doi S; Hamada T
    Intern Med; 2007; 46(11):743-5. PubMed ID: 17541227
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Myasthenia gravis in a young Papuan woman.
    Trevett AJ; Nwokolo N
    P N G Med J; 1993 Sep; 36(3):243-5. PubMed ID: 8059551
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Myasthenic Crisis as the First Presentation of Myasthenia Gravis: A Case Report.
    Payus AO; Leow Wen Hsiang J; Leong JQ; Ibrahim A; Raymond AA
    Am J Case Rep; 2021 Jan; 22():e928419. PubMed ID: 33468985
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Paraneoplastic pemphigus as the presenting symptom of a lymphoma of the tongue.
    van der Waal RI; Pas HH; Anhalt GJ; Schulten EA; Jonkman MF; Nieboer C
    Oral Oncol; 1998 Nov; 34(6):567-70. PubMed ID: 9930372
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Myasthenia gravis, an autoimmune manifestation of lymphoma and lymphoproliferative disorders: case reports and review of literature.
    Rezania K; Soliven B; Baron J; Lin H; Penumalli V; van Besien K
    Leuk Lymphoma; 2012 Mar; 53(3):371-80. PubMed ID: 21864038
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [A patient of chronic graft-versus-host disease presenting simultaneously with polymyositis and myasthenia gravis].
    Yanagihara C; Nakaji K; Tanaka Y; Yabe H; Nishimura Y
    Rinsho Shinkeigaku; 2001 Aug; 41(8):503-6. PubMed ID: 11889835
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Paraneoplastic myasthenia gravis: detection of anti-MGT30 (titin) antibodies predicts thymic epithelial tumor.
    Voltz RD; Albrich WC; Nägele A; Schumm F; Wick M; Freiburg A; Gautel M; Thaler HT; Aarli J; Kirchner T; Hohlfeld R
    Neurology; 1997 Nov; 49(5):1454-7. PubMed ID: 9371941
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Myasthenia Gravis: Unusual Presentations and Diagnostic Pitfalls.
    Rodolico C; Parisi D; Portaro S; Biasini F; Sinicropi S; Ciranni A; Toscano A; Messina S; Musumeci O; Vita G; Girlanda P
    J Neuromuscul Dis; 2016 Aug; 3(3):413-418. PubMed ID: 27854225
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Myasthenia gravis masquerading as acute stroke: a case report.
    Menon SMR; Mokkath NR
    Pan Afr Med J; 2020; 37():305. PubMed ID: 33654524
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Myasthenia gravis with a paraneoplastic marker.
    Leavitt JA
    J Neuroophthalmol; 2000 Jun; 20(2):102-5. PubMed ID: 10870923
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dermatomyositis and concomitant overlap myasthenic syndrome: a rare presentation.
    Hill EK; King PH; Hughey LC
    J Am Acad Dermatol; 2011 Nov; 65(5):e150-2. PubMed ID: 22000887
    [No Abstract]   [Full Text] [Related]  

  • 35. Preanesthetic train-of-four fade predicts the atracurium requirement of myasthenia gravis patients.
    Mann R; Blobner M; Jelen-Esselborn S; Busley R; Werner C
    Anesthesiology; 2000 Aug; 93(2):346-50. PubMed ID: 10910480
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Paraneoplastic neurological manifestations of pulmonary neoplasms. Apropos of 2 case reports].
    Buysschaert M; Henriet M; Lecomte J; Jacquy J; Gilbert P; Thiriaux J
    Rev Med Brux; 1988 Sep; 9(6):313-6. PubMed ID: 2845553
    [No Abstract]   [Full Text] [Related]  

  • 37. Development of myasthenia gravis after interferon alpha therapy.
    Gurtubay IG; Morales G; Aréchaga O; Gállego J
    Electromyogr Clin Neurophysiol; 1999 Mar; 39(2):75-8. PubMed ID: 10207675
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence of myasthenia gravis and associated autoantibodies in paraneoplastic pemphigus and their correlations with symptoms and prognosis.
    Wang R; Li J; Wang M; Hao H; Chen X; Li R; Zhu X
    Br J Dermatol; 2015 Apr; 172(4):968-75. PubMed ID: 25388377
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Onset and Evolution of Clinically Apparent Myasthenia Gravis After Resection of Non-myasthenic Thymomas.
    Mineo TC; Tamburrini A; Schillaci O; Ambrogi V
    Semin Thorac Cardiovasc Surg; 2018; 30(2):222-227. PubMed ID: 29522809
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Myopathy in Childhood Muscle-Specific Kinase Myasthenia Gravis.
    Kirzinger L; Khomenko A; Schulte-Mattler W; Backhaus R; Platen S; Schalke B
    Pediatr Neurol; 2016 Dec; 65():90-92. PubMed ID: 27697312
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.